Northern Trust’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-86,824
| Closed | -$75.5K | – | 4559 |
|
|
2023
Q2 | $75.5K | Hold |
86,824
| – | – | ﹤0.01% | 4112 |
|
|
2023
Q1 | $60.7K | Buy |
86,824
+26,919
| +45% | +$21.8K | ﹤0.01% | 4213 |
|
|
2022
Q4 | $49.1K | Hold |
59,905
| – | – | ﹤0.01% | 4289 |
|
|
2022
Q3 | $62K | Buy |
59,905
+4,750
| +9% | +$7.59K | ﹤0.01% | 4268 |
|
|
2022
Q2 | $90K | Sell |
55,155
-241,944
| -81% | -$502K | ﹤0.01% | 4214 |
|
|
2022
Q1 | $873K | Sell |
297,099
-14,040
| -5% | -$49.2K | ﹤0.01% | 3486 |
|
|
2021
Q4 | $1.49M | Buy |
311,139
+18,370
| +6% | +$119K | ﹤0.01% | 3371 |
|
|
2021
Q3 | $2.22M | Buy |
292,769
+6,068
| +2% | +$38.8K | ﹤0.01% | 3233 |
|
|
2021
Q2 | $2.14M | Buy |
286,701
+247,492
| +631% | +$1.91M | ﹤0.01% | 3324 |
|
|
2021
Q1 | $306K | Buy |
39,209
+1,113
| +3% | +$11.1K | ﹤0.01% | 3976 |
|
|
2020
Q4 | $352K | Sell |
38,096
-807
| -2% | -$7.01K | ﹤0.01% | 3814 |
|
|
2020
Q3 | $268K | Buy |
38,903
+21,531
| +124% | +$131K | ﹤0.01% | 3750 |
|
|
2020
Q2 | $114K | Hold |
17,372
| – | – | ﹤0.01% | 3884 |
|
|
2020
Q1 | $32K | Buy |
17,372
+2,762
| +19% | +$7.28K | ﹤0.01% | 4023 |
|
|
2019
Q4 | $27K | Hold |
14,610
| – | – | ﹤0.01% | 4127 |
|
|
2019
Q3 | $21K | Sell |
14,610
-95,877
| -87% | -$209K | ﹤0.01% | 4150 |
|
|
2019
Q2 | $311K | Sell |
110,487
-7,398
| -6% | -$29.4K | ﹤0.01% | 3690 |
|
|
2019
Q1 | $562K | Sell |
117,885
-1,552
| -1% | -$7.64K | ﹤0.01% | 3514 |
|
|
2018
Q4 | $506K | Buy |
119,437
+39,964
| +50% | +$309K | ﹤0.01% | 3547 |
|
|
2018
Q3 | $869K | Buy |
79,473
+158
| +0.2% | +$1.85K | ﹤0.01% | 3508 |
|
|
2018
Q2 | $1.29M | Buy |
+79,315
| New | +$1.15M | ﹤0.01% | 3395 |
|
Northern Trust's SURF Position: Q3 2023 in Review
Northern Trust sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 86,824 shares — an estimated $75.5K sold.
Northern Trust first reported a position in SURF in Q2 2018 and held it in 21 quarters. The position peaked at $2.22M in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Northern Trust reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 86,824 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $75.5K.
- Northern Trust first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- Northern Trust's Surface Oncology, Inc. Common Stock position peaked at $2.22M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.